Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 2201 - 2225 of 3913 in total
Main Class Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT03
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261590 1282.812543 C64H118N2O23
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF03
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261670 1282.812543 C64H118N2O23
Neutral glycosphingolipids GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AA08
  • GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • asialo-GM2(d18:1/26:1(17Z))
 44260491 1202.837968 C64H118N2O18
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA08
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Lc3Cer(d18:1/26:1(17Z))
 44260619 1202.837968 C64H118N2O18
Neutral glycosphingolipids GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA08
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261955 1202.837968 C64H118N2O18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM01
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260260 1347.776219 C64H117NO28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AU01
  • Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260324 1331.781304 C64H117NO27
Neutral glycosphingolipids GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN02
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44260589 1295.807792 C64H117N3O23
Acidic glycosphingolipids Gangliosides LMSP0601DH05
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44262616 1223.811814 C63H117NO21
Acidic glycosphingolipids Gangliosides LMSP0601AJ04
  • GM3(d18:1/22:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
 44262039 84679 1236.807063 C63H116N2O21
Acidic glycosphingolipids Gangliosides LMSP0601DH07
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44262618 1221.796164 C63H115NO21
Acidic glycosphingolipids Gangliosides LMSP0601DC01
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44262572 1314.765988 C63H114N2O26
Acidic glycosphingolipids Gangliosides LMSP0601DG01
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • KDN-GM2(d18:1/16:0)
 44262604 1314.765988 C63H114N2O26
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA06
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Gb3(d18:1/26:0)
 44260169 75188 1163.827069 C62H117NO18
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ06
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Isoglobotriglycosylceramide(d18:1/26:0)
 44261569 73269 1163.827069 C62H117NO18
Neutral glycosphingolipids Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA06
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0)
 44261945 1163.827069 C62H117NO18
Neutral glycosphingolipids GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AA05
  • GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • asialo-GM2(d18:1/24:0)
 44260488 1176.822318 C62H116N2O18
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA05
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Lc3Cer(d18:1/24:0)
 44260616 1176.822318 C62H116N2O18
Neutral glycosphingolipids GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA05
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261952 1176.822318 C62H116N2O18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL03
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44260254 1241.785994 C62H115NO23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO03
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44260278 1241.785994 C62H115NO23
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BD03
  • Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261654 1241.785994 C62H115NO23
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA03
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261854 1225.791079 C62H115NO22
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261622 1225.791079 C62H115NO22
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA08
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Gb3(d18:1/26:1(17Z))
 44260171 133816 1161.811419 C62H115NO18
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024